Mycoplasma infection is on the rise in recent times. It usually infects any system, including liver. This study aims to show the significance of elevated liver enzymes in mycoplasma pneumonia and to have a look at future prospects. This is a single-center retrospective study involving 105 children serologically positive for mycoplasma IgM and IgG antibodies and 50 with community-acquired pneumonia caused by organisms other than mycoplasma and Epstein-Barr virus from June 2015 to June 2016 and all without prior liver disease. The patients were followed after 10 days (7-14 days). The liver enzymes were significantly elevated in Mycoplasma pneumoniae infection. The mean levels of alanine transaminase and aspartate transaminase were 39.3 and 32.5 IU/L, respectively. There was a seasonal variation during the months of September and February. Liver involvement in mycoplasma pneumonia is mostly a benign condition and asymptomatic. It is insisted that children with continued elevation should be followed conservatively to avoid unnecessary diagnostic procedures in the future.
Introduction
Mycoplasma pneumoniae is an exclusively human pathogen and frequently causes atypical pneumonia in the age group of 3 to 15 years. It accounts for 7% to 66.7% of total community-acquired pneumonia cases. 1 Epidemics of mycoplasma pneumonia have been seen in many parts of the world. The clinical findings vary from a mild febrile respiratory illness to fatal pneumonia. Severe mycoplasma pneumonia may be seen in the defined age groups and bronchopneumonia may be seen in older children (5-15 years) . Mycoplasma pneumoniae is known to cause a variety of extrapulmonary diseases, and it can cause multiorgan damage 2, 3 involving the nervous system (aseptic meningitis), hematologic system (anemia), cardiovascular system (myocarditis), skeletal system (arthritis), renal system (glomerulonephritis), skin (rash), and gastrointestinal system (hepatitis, pancreatitis). 4, 5 Hepatitis associated with Mycoplasma is around 10% to 30%, 6 its prevalence is less. Cholestatic hepatitis is also reported in children and adults. 7, 8 Mycoplasma pneumonia also shows the asymptomatic elevation of liver enzymes. Alanine transaminase (ALT), aspartate transaminase (AST), and lactate dehydrogenase (LDH) values are elevated significantly after infection indicating the involvement of liver in the course of the disease and the levels normalize after a macrolide therapy. The patients may not experience any symptoms because of this elevation. This elevation has to be studied prospectively to further evaluate the degree of liver damage.
Materials and Methods
The study was conducted retrospectively at a single center in the Second Affiliated Hospital of Dalian Medical University, China between June 2014 and June 2016. The study was done to compare the liver enzyme levels between the study and the control groups and to identify the age and gender distribution, seasonal variation, and the effect of macrolide therapy on elevated liver enzymes and also to know if there was any correlation with hemoglobin levels.
Study Design
A total of 155 patients without prior liver disease and with no history of drug intake were included in the study. A total of 105 children were included in the study group and 50 in the control group. The study group included the children who are positive for IgM and IgG antibodies and a cold agglutinin titer ≥1:60. Patients positive for Epstein-Barr virus (EBV) and hepatitis A, B, and C viruses were excluded from this group. The control group included children with community-acquired pneumonia other than mycoplasma pneumonia and EBV. All the children had a radiological evidence of pneumonia. The children in the study group were further grouped according to their age into 2 groups, 1 to 5 years (69 cases) and 6 to 10 years (35 cases).
Laboratory Evaluation
To confirm mycoplasma pneumonia, IgM antibody was tested using a commercial enzyme-linked immunosorbent assay (ELISA) kit. To assess the liver function, serum levels of ALT, AST, LDH, alkaline phosphatase (ALP), and gamma-glutamate dehydrogenase (GGT) were measured. ALT levels were taken as a specific indicator of liver damage.
ALT and AST levels were measured by enzyme immunoassay method (Siemens, New York, NY, USA). Reference ranges for ALT were 0 to 19 IU/L (female) and 0 to 23 IU/L (male). A second ALT level was measured during convalescence (7-14 days from the date of admission, average 10 days). Radiograph was taken on the day of admission. Ultrasound examination was done to assess the size of the liver.
Statistical Analysis
Statistical analyses were performed using IBM SPSS 20.0 version. Continuous variables were expressed as mean ± standard deviation. Pearson chi-square test was done for categorical variables. Independentsamples t test and paired t test were done for continuous variables. Pearson correlation test was done to find a correlation. A 2-sided P value ≤.05 was considered statistically significant.
Results

Demographic Characteristics
A total of 105 patients with mycoplasma pneumonia were included in the study group from June 2015 to June 2016. Of them, 52 (49.5%) were males and 53(50.4%) were females with a male:female ratio of 1:1.01. The age of the patients ranged from 1 to 9 years with a mean of 4.5 ± 2.2 years and a median of 4 years.
The infection was confirmed by serology. All the patients were treated with macrolides and some had prednisolone added in the treatment depending on the severity. Admission in the intensive care unit was not required for any of them.
Clinical Presentation
Fever was the most common symptom, seen in 95 cases (90%) followed by cough seen in 82 cases (78%). Coarse breathing sound, wheeze, rales, respiratory distress, and tonsillar enlargement were among the other respiratory findings. Symptoms like dyspnea, diarrhea, and headache were seen in some of the patients. Rash was seen in 25 cases (23.8%). Pneumonia was confirmed radiologically. Radiograph showed lobar or bronchial or interstitial pattern. No pleural effusion was noted. Hepatomegaly was seen in 3 patients.
The elevation of liver enzymes showed a seasonal variation with an increased number of cases during September and February. There were 46 cases (76.6%) with elevated liver enzymes during this period (Figure 1 ). There was no significant age and gender difference (P > .05) among the mycoplasma pneumonia patients with and without elevated liver enzymes. None was offered liver biopsy. Serum ALT, AST, LDH, ALP, and GGT levels were measured for the assessment of liver function. Serum ALT levels were elevated in 66 (62.8%) patients of mycoplasma pneumonia and in 6 (12%) cases of patients with community-acquired pneumonia other than mycoplasma. The mean and median ALT values in patients with mycoplasma pneumonia were 39.3 ± 22.3 and 41 IU/L, respectively. AST had a mean of 32.5 ± 12.9 IU/L and a median of 28 IU/L. The mean LDH was 305 ± 65.9 IU/L and a median of 293 IU/L. The mean ALT and AST levels in the study group were elevated than in the control group: 39.3 and 32.5 versus 14.4 and 19.7, respectively. There was significant difference in this elevation (P = .000) (Figure 2 ) whereas there was no statistical difference in LDH (P = .37) values in both the groups.
All the patients were treated with macrolides for an average period of 5 days. A second measurement of serum ALT levels was done after a median interval of 10 days for the patients with initial elevated ALT values. The serum ALT levels decreased in 46 patients and there was no change in the levels in 10 cases and in 4 patients the levels were elevated than before. There was a significant difference in the mean ALT levels before and after (39.3 vs 24.5 IU/L) the treatment with macrolides. (P < .05).
The mean ALP and GGT were 168.3 ± 42.8 IU/L and 10.42 ± 4.2 U/L, respectively. The neutrophil count was increased (>70%) in 12 cases (11.4%) and decreased (<40%) in 36 cases (34.2%). The median neutrophil count was 48.94%. C-reactive protein (CRP) was elevated in 50 cases (47.6%) and the mean CRP was 16.8±18.58 mg/L. The mean hemoglobin was 123.8 ± 8.8 mg/dL and the hemoglobin was less than 130 mg/dL in 78 (74.2%) cases. There was no correlation between hemoglobin values and elevated liver enzymes (r 2 = 0.07, P = .426).
Discussion
The epidemiological characteristics may be different among populations for mycoplasma pneumonia. 9 Children may be asymptomatic reservoirs and may cause outbreaks in families. 10 Extra pulmonary manifestations are seen in one-fifth of the patients hospitalized for mycoplasma pneumonia. 11 Mycoplasma pneumonia induced hepatitis was described early in 1975. 12 The incidence of hepatitis in mycoplasma pneumonia may be up to 30%. 6, 13 Hepatitis may be of hepatocellular origin or cholestatic. The pathogenesis is poorly understood. The mechanism causing liver damage may be immune mediated (autoimmune antibodies) as indicated by the presence of cold agglutinins 3, 14, 15 or it may be immunological indicated by cross-reactive antibodies to sialo-oligosaccharides on hepatocytes. 16 Mycoplasma may also cause damage by directly invading the liver. ALT and AST levels indicate the degree of hepatocellular injury. ALP and GGT represent cholestatic injury. Serum ALT and AST levels increase significantly with necrosis and destruction of mitochondria and endoplasmic reticulum. Quick response of ALT and AST to hepatocellular damage is because of their short half-life (1-2 days). 17 Sensitivity and specificity of ALT is around 83% 18 and is more specific than AST for liver function. The elevation of liver enzymes may be asymptomatic as seen in our study. We observed the elevation of ALT levels in 60 cases (57.14%) of mycoplasma pneumonia as compared with 6 (12%) cases of community-acquired pneumonia other than mycoplasma pneumonia. We observed a median ALT of 39.3 ± 22.3 IU/L with a maximum value of 110 IU/L and a median AST of 32.5 ± 12.9 IU/L. On second measurement, we found that the levels decreased in 46 cases after a median interval of 10 days. We found that there were no cases of hyperbilirubinemia and jaundice. Liver biopsy was not performed in any of the patients but the liver biopsy done by other researchers showed a nonspecific reactive hepatitis 19 and some had severe and lobular hepatitis. 20 In our study, serum LDH was elevated in 100 (95.2%) cases of mycoplasma pneumonia with a median of 293 IU/L. Other studies showed that LDH was elevated in obstructive and interstitial lung diseases as well as in mycoplasma pneumonia. 9, 21, 22 Serum LDH levels cannot be used as a marker for lung injury as it is elevated in several other conditions but it can be used as a biomarker to initiate the steroid treatment. 21, 23 Figure 2. The serum alanine transaminase (ALT) levels were significantly higher in the study group as compared with the control group.
We observed that the elevation was more during the months of September and February. There were 80 cases (76.1%) of mycoplasma pneumonia during this period and 46 cases had elevated liver enzymes. It has been reported that the mycoplasma pneumonia was more common at 0 to 6 years of age, 24 ,25 but we did not find any relation between age, gender and elevated liver enzymes.
Studies showed that mycoplasma is associated with neutrophilia, 26 we observed neutropenia in 36 patients and neutrophilia in 12 cases. CRP was increased in 50 cases (47.6%) with a median of 7.9 IU/L. The median hemoglobin observed was 123 mg/ dL. There were 78 cases where hemoglobin was less than 130 mg/dL. No correlation was found between hemoglobin levels and elevated liver enzymes. No change in the length of hospitalization was found in our study whereas Kim et al 27 observed a longer duration of hospital stay.
Limitations
Retrospective nature of the study is the main limitation of our study. We are not certain whether the IgM, based on which Mycoplasma pneumonia is diagnosed, is from present or past infection because the IgM takes around 6 months to disappear from the blood. Follow-up of the children for further testing is another limitation to our study.
Conclusions
We conclude that elevated liver enzymes are a common finding in children with mycoplasma pneumonia with a good prognosis. This elevation may be asymptomatic or may lead to hepatitis. The elevation is a benign condition and has to be followed conservatively as the children might develop complications at a later stage of life. There are no prospective studies done on this asymptomatic elevation in children. Further prospective studies on the pattern of elevation and their long-term effect on liver and further complications have to be done. This should be done to avoid unnecessary diagnostic tests and liver biopsy at a later stage. This will further help understand the course of the disease.
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